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Independent Testing Labs Authorized to Start Testing Products for the Adult-Use Cannabis Industry 
 
FOR IMMEDIATE RELEASE:                             November 7, 2018 
 
BOSTON—The Cannabis Control Commission (Commission) has authorized two independent testing 
laboratories to start testing marijuana and marijuana products for the adult-use cannabis industry as 
Massachusetts prepares to open the first retail establishments on the East Coast. 
 
On Wednesday, MCR Labs, LLC and CDX Analytics, LLC received notices to commence operations after they 
satisfied specified conditions, passed inspections, fingerprinted lab agents, and became established in Metrc, a 
mandatory seed-to-sale tracking system that records and verifies when production batches have been tested. 
The Commission’s authorization gives laboratories a minimum of three calendar days to coordinate opening 
day logistics with their host community, local law enforcement, marijuana establishment colleagues, and other 
essential stakeholders before adult-use operations begin.  
 
“When Massachusetts voters legalized adult-use cannabis, they communicated a desire to purchase products 
that are safely regulated and properly tested,” Commission Executive Director Shawn Collins said. “The 
Commission has done scrupulous due diligence to make that vision a reality and ensure licensed independent 
testing labs maximize public health and public safety.” 
 
MCR Labs and CDX Analytics already test Registered Marijuana Dispensary (RMD) inventory under the 
Medical Use of Marijuana Program managed by the Department of Public Health (DPH). Chapter 55 of the 
Acts of 2017 requires adult-use marijuana and marijuana products to be tested by Commission-licensed 
laboratories before they are sold in Massachusetts. RMDs that obtain a marijuana establishment license from 
the Commission may transfer existing medical inventory for adult-use sales if they can demonstrate it has been 
previously tested by either lab and the products comply with the Commission’s regulations. 
 
Licensees must have products and environmental media tested according to DPH standards including the 
Protocol for Sampling and Analysis of Finished Medical Marijuana Products and Marijuana-infused Products 
and the Protocol for Sampling and Analysis of Environmental Media for Massachusetts Registered Medical 
Marijuana Dispensaries. When testing reveals any product contamination that cannot be remediated, 
laboratories and establishments must notify the Commission within 72 hours and dispose of the batch. 
 
The Commission requires independent testing laboratories to be accredited to the International Organization for 
Standardization 17025 (ISO/IEC 17025:2017). Laboratories also must be financially independent from any 
licensee for which they conduct a test and are not permitted to hold another type of license. 
 
In total, the Commission has approved 64 provisional licenses of which 12 final licenses have been approved 
toward implementing the adult-use cannabis industry in Massachusetts. Prior to final licensees obtaining a 
notice to commence operations for cultivation, product manufacturing, or retail, they may submit existing 
inventory to laboratories to begin testing. 
 
To learn more about independent testing laboratories or the licensing process, contact the Commission at 617-
701-8400 or CannabisCommission@mass.gov, or follow the Commission on Facebook and Twitter.   
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